Background: Concurrent multifactorial treatment is needed to reduce consequent risks
| INTRODUCTION
Diabetes is one of the leading causes of death globally with an ever increasing prevalence; the age-standardized diabetes prevalence increased from 4.3% in 1980 to 9.0% in 2014 in men, and from 5.0% to 7.9% in women. Type 2 diabetes mellitus stands for about 85 to 90% of all cases. 1 Recommendations for the management of type 2 diabetes mellitus include rigorous control of blood glucose levels and other risk factors, such as hypertension and dyslipidaemia.
Furthermore, patients with type 2 diabetes mellitus are at high risk of cardiovascular disease (CVD)-the leading cause of death in these patients. Because of the adverse health effects related to the disease, diabetes is also accompanied by an economic burden on individuals as well as on health-care systems. 2 In addition, diabetes have strong adverse effects on the labour market. 2 Good diabetes care is crucial to delay the complications and limit the costs. Different patient groups are, however, unequally affected by type 2 diabetes mellitus, determined
by, e.g., sex, age, and ethnicity. Socioeconomic inequalities are also reflected in diabetes care and are often associated with differences in process indicators of care and intermediate health outcomes, resulting in varying risks of both microvascular and macrovascular complications. 3 The Swedish health-care system is mainly tax-funded; individual costs represent a minor fraction of actual costs. It aims at being a socially responsible system with a clear public commitment to ensure the health of all citizens. 4 Thus, studying type 2 diabetes mellitus care in Sweden is of interest because Swedish health care provides an environment that should facilitate equal health outcomes in patients, independent of background, socioeconomic status, or health profile. The relationship between social determinants of health and health outcomes has been established but is not well understood. 5 Previous literature point to differences in diabetes care between sociodemographic groups in differences in HbA 1c , CVD risk, low-density lipoprotein (LDL) cholesterol and blood pressure. [5] [6] [7] In addition, a large Swedish study based on the National Diabetes Register (NDR) showed that socioeconomic status (country of birth, education, income, marital status, and occupation) was a strong predictor of both cardiovascular and diabetes-related mortality. 8 Most of the studies conducted so far, however, focused on only 1 risk factor (mainly glycaemic control) even if concurrent multifactorial treatment is needed to reduce consequent risks of diabetes. In addition, few studies simultaneously assessed the impact of multiple determinants on diabetes-related health outcomes, and many of the studies are limited by small sample sizes and low statistical power. 
| OUTCOMES
The quality of diabetes care was evaluated based on 5 outcomes:
absolute HbA 1c level after 1 year of follow-up, systolic blood pressure, LDL levels after 1 year of follow-up, predicted 5-year risk of CVD after 1 year of follow-up, 10 and prescribed statins.
| Traditional risk markers
Traditional risk markers of diabetes care were collected from the NDR. 
| Statin use
We used information on filled statin prescriptions identified from the Swedish Prescribed Drug Registry as a proxy for statin use. Statins were defined as Anatomical Therapeutic Chemical classification codes C10AA01-08.
| CASEMIX FACTORS
Casemix factors were selected based on the literature, the clinical expertise of the multiprofessional expert group, and data availability. All models were adjusted for age (grouped in 5-year intervals), sex (male/female), highest level of education (≤9 years, 10-12 years, and >12 years), region of birth (within the Nordic countries, the European Union [EU], Europe but not the EU, or outside Europe), and marital status (married, never married, divorced, and widowed). Additional casemix factors for each specific outcome are described in Table 1 .
To assess the impact of the casemix factors on the study variables, regression analysis was adjusted for clustering of health outcomes within individual patients when computing the 95% confidence intervals (CIs) of each casemix factor's effect on the outcome, as some patients contributed with two 1-year episodes. Multiplicative interactions were tested by using the likelihood ratio test. Two-sided P values less than .05 were considered statistically significant.
| RESULTS
The study population consisted of 537,025 one-year episodes of previously known type 2 diabetes mellitus registered during 2010 to Being born in Europe outside of the EU or being born outside Europe was associated with higher HbA 1c levels (P < .001 for both).
Smoking (P = .002), duration of diabetes (per year, P < .001) and BMI (per unit, P < .001) were all individually associated with higher levels of HbA1c. A history (previous two years) of CVD (P < .001), eye disease (P = .006), or lower extremity complications (P = .004)
were associated with higher levels of HbA 1c . Coefficients are presented in Table S1 .
Results from the multivariate regression analysis on blood pressure are presented in Figure 2 . When modelling systolic blood pressure continuously, in addition to higher age, lower educational level was associated with higher systolic blood pressure (P = .002 for educational level <9 years and P < .001 for educational level 10-12 years compared with educational level of >12 years). Being married (P < .001) or being divorced (P = .004) was associated with lower systolic blood pressure compared with never being married. Region of birth was associated with systolic blood pressure; being born in a non-EU European country was associated with higher systolic blood pressure (P = .01), whereas being born outside Europe was associated with lower systolic blood pressure (P < .001) compared with being born within the Nordic countries. Both estimated GFR (per unit, P < .001),
HbA 1c (per unit, P < 0.001), LDL (per unit, P < .001) and BMI (per unit, P = .009) at baseline were associated with higher blood pressure. A history (previous two years) of atrial fibrillation, depressive episode, or other psychiatric conditions were associated with lower systolic blood pressure (P < .001, P = .004, and P < .001, respectively).
Coefficients are presented in Table S2 .
We also assessed the effect of sociodemographic and other baseline determinants on the risk of having a blood pressure above 140/85 mm Hg ( Figure S1 ). The pattern between the determinants and dichotomous blood pressure was the same as compared with modelling systolic blood pressure continuously. ICD-10 codes: I20-I25 (angina pectoris, myocardial infarction, other acute ischemic heart diseases, and chronic ischemic heart disease), I61 (intracerebral haemorrhage), and I63-I64 (cerebral infarction and stroke not specified as haemorrhage or infarction). Results from the multivariate regression analysis on LDL levels are presented in Figure 3 .
Being a woman was associated with higher LDL levels as compared with being a man (P < .001). Age did not seem to be associated with LDL levels, with the exception of the youngest age group; individuals 18 to 49 years of age had higher LDL levels compared with those ≥75 years of age (P = .003). Estimated GFR levels at baseline were associated with higher LDL levels (per unit, P < .001), whereas duration of diabetes (per year, P < .001) and BMI at baseline (per unit, P < .001) were associated with lower levels of LDL. A history (previous two years) of CVD (P < .001) and a history of atrial fibrillation (P = .002) were both associated with lower levels of LDL. Coefficients are presented in Table S3 .
| DETERMINANTS OF PREDICTED 5-YEAR RISK OF CVD
Results from the multivariate regression analysis on estimated 5-year risk of CVD are presented in Figure 4 . Being a woman was associated with lower CVD risk (P < .001) as well as being younger (P < .001 for all age groups compared with being 65-74 years of age). Lower education was consistently associated with higher 5-year risk of CVD, high school education versus college/university degree (P = .04), and comprehensive school versus college/university degree (P = .01). Being born in Europe, but outside of the EU, or being born outside Europe was also associated with a higher 5-year risk of CVD (P = .003 and P < .001, respectively) compared with being born within the Nordic Table S4 .
The predictive model for 5-year risk of CVD used in this study was validated for the age span of 30 to 74 years 10 ; thus, we used the same age span in our analysis. As a sensitivity analysis, we also modelled the predicted 5-year risk of CVD by using the whole population, i.e., aged 18 years or older. Results did not differ substantially from the analysis including individuals aged 30 to 74 years only (data not shown). In addition, comparison of a number of baseline characteristics such as BMI, diabetes duration, and HbA 1c between the group analysed and the total study population showed no notable differences (data not shown).
| DETERMINANTS OF STATIN USE
Results from the multivariate regression analysis on statin use are presented in Figure 5 . Being in the age group 18 to 49 years was associated with lower statin use (odds ratio [OR] 0.75, 95% CI: 0.65-0.86), whereas being 50 to 74 years was associated with increased statin use (P = .01 for ages 50-54 and P < 0.01 for all Table S5 .
We also investigated whether the association between region of birth and each specific outcome was modified by educational level.
Among individuals with comprehensive school or a college/university degree as highest educational level, born within the EU appeared to be associated with a higher HbA 1c level, whereas for individuals with a high school degree, no statistically significant association was observed (P for interaction = .04). Among individuals with comprehensive school as highest educational level, born outside Europe appeared to be somewhat weaker associated with 5-year risk of CVD compared with those with a high school or college/university degree (P for interaction <.001). We did not observe any support for a modification by educational level for the other outcomes assessed (P for interaction = .68 for systolic blood pressure, .75 for LDL levels, and .31 for prescribed statins).
| DISCUSSION
In this retrospective registry study on individuals with prevalent type 2 diabetes mellitus in Sweden, we observed casemix-adjusted 20 In a Hong Kong-based study of 1,970 patients with type 2 diabetes mellitus, patients in successive older age groups were more likely to achieve the HbA 1c target (≤7%; P for trend<.01).
21
Women were 17% less likely to achieve the HbA 1c target compared with men (P = .04).
The strengths of this study include a large sample size-covering most Swedish individuals with type 2 diabetes mellitus-and the ability to adjust for a broad range of sociodemographic factors and diabetesrelated complications due to the unique linkage of data from patient administrative systems, the NDR, Statistics Sweden, and the Prescribed Drug Registry. In addition, the Swedish Healthcare Quality
Registries (whereof the NDR is 1) are of recognized high quality with a high proportion of completeness (in the case of NDR: 75% overall and >90% in certain subgroups), thus enabling collection of detailed information on disease-specific data. 22 Validation studies of the NDR have also shown a high level of accuracy. 23 There are, however, several limitations. This study was based on available retrospective registry data, not allowing for control of a potential systematic bias in registration of data. The analysis of determinants of 5-year risk for CVD excluded a large number of episodes due to the high number of parameters included in the algorithm (only 3,387 of 416,228 episodes could be included in this analysis). In addition, the algorithm was only validated for the age range of 30 to 74 years, which limited the number of observations included in the analysis additionally. The implications of our findings must also be considered within the context of the time period available for examination as diabetes care processes could have changed during later years. In addition, generalizations regarding other regions and other countries (also subject to other health-care systems)
should be made with caution.
Based on findings from the present study, we conclude that diabetes care in Sweden is unequal. In addition to demographic factors (age and sex) and disease history, educational level, marital status, and region of birth are important factors to take into consideration when benchmarking health outcomes, e.g., average HbA 1c level, and evaluating the level of health equity between organizational units or between different administrative regions. These results highlight the importance of more personcentred care based on individual and sociodemographic needs.
